Home | Business News | Browse by Publication | F | FDA Consumer

Ulcerative colitis treatment for children and teens.

Publication: FDA Consumer
Publication Date: 01-MAR-07
Format: Online
Delivery: Immediate Online Access
Full Article Title: Ulcerative colitis treatment for children and teens.(Updates)(Salix Pharmaceuticals Inc.)(Brief article)

Article Excerpt
Colazal (balsalazide disodium) has been approved for the treatment of mildly to moderately active ulcerative colitis in patients ages 5 years to 17 years. This type of bowel disease causes inflammation of the colon and rectum, and affects about 5 per 100,000 children in the United States each year....



More articles from FDA Consumer
New drug to treat cyanide poisoning.(Updates)(Cyanokit; Merck Sante SA..., March 01, 2007
Device prevents brain damage in infants.(Updates)(Olympic Medical Corp..., March 01, 2007
Loneliness associated with increased risk of Alzheimer's disease.(Rese..., March 01, 2007
General Electric's OEC Medical Systems signs consent decree.(prohibiti..., March 01, 2007

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.